Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Humanetics and USAMRICD enter into CRADA to study BIO-300 to treat phosgene exposure

Feb. 26, 2014

FDA clears path for smoking cessation trial of INV-102

Jan. 30, 2014

Phase I study of novel treatment candidate for alcoholism begins patient recruitment

Jan. 27, 2014

FDA grants orphan drug status to Aeolus' drug candidate for treatment of acute radiation syndrome

Jan. 24, 2014

Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation

Jan. 10, 2014

Neumedicines joins the Alliance for Biosecurity

Jan. 7, 2014

Takeda submits NDA for fomepizole in Japan

Dec. 30, 2013

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Characterization of novel cocaine metabolizing enzymes for treatment of addiction

Dec. 10, 2013

VMY-2-109 treatment leads to reduction in nicotine self-administration in vivo

Nov. 27, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...